Anteilseigner
BVF Partners LP (15,91 %) Paradigm BioCapital Advisors LP (14,13 %) Logos Global Management LP (5,78 %) Deep Track Capital LP (5,77 %) SSgA Funds Management, Inc. (5,68 %) BlackRock Fund Advisors (5,01 %) The Vanguard Group, Inc. (4,20 %) MPM BioImpact, Inc (3,49 %) Vivo Capital LLC (3,35 %) Dimensional Fund Advisors LP (3,25 %) Janus Henderson Investors US LLC (2,15 %) Cyrus L. Harmon,
PhD (1,58 %) Geode Capital Management LLC (1,50 %) Wellington Management Co. LLP (1,49 %) Citadel Advisors LLC (1,36 %) Woodline Partners LP (1,34 %) Polar Capital LLP (1,34 %) David C. Myles,
PhD (1,33 %) Soleus Capital Management LP (Investment Management) (1,18 %)
Kontakt
Olema Pharmaceuticals Inc.